Deep Genomics

Deep Genomics is a Toronto-based biotechnology company at the forefront of AI-powered drug discovery. Founded in 2015 by Brendan Frey, a professor at the University of Toronto and co-founder of the Vector Institute for Artificial Intelligence, the company has built proprietary AI platforms that untangle the complexity of RNA biology to identify novel therapeutic targets and evaluate thousands of drug candidates. Deep Genomics' technology suite includes BigRNA, the world's first AI foundation model for RNA biology, and its successor BigRNA+, which expands target identification into complex genetic diseases. The interdisciplinary team of 100+ experts spans artificial intelligence, molecular biology, machine learning, organic chemistry, and clinical development. The company has deep scientific advisory relationships with Yann LeCun and other leading researchers.